scispace - formally typeset
F

Fikriye Uras

Researcher at Marmara University

Publications -  42
Citations -  563

Fikriye Uras is an academic researcher from Marmara University. The author has contributed to research in topics: Platelet & Platelet activation. The author has an hindex of 12, co-authored 40 publications receiving 530 citations. Previous affiliations of Fikriye Uras include FIU Herbert Wertheim College of Medicine.

Papers
More filters
Journal ArticleDOI

A Novel Antioxidant N-acetylcysteine Amide Prevents Gp120- and Tat-Induced Oxidative Stress in Brain Endothelial Cells

TL;DR: These studies show that NACA reverses gp120- and Tat-induced oxidative stress in immortalized endothelial cells, and HIV-1 protein-induced toxicity in these cells was blocked by treatment with NACA.
Journal ArticleDOI

Silymarin protects liver against toxic effects of anti-tuberculosis drugs in experimental animals

TL;DR: The active components of silymarin had protective effects against hepatotoxic actions of drugs used in the chemotherapy of tuberculosis in animal models and can be used as a dietary supplement by patients taking anti-tuberculosis medications.
Journal ArticleDOI

Do platelet apoptosis, activation, aggregation, lipid peroxidation and platelet-leukocyte aggregate formation occur simultaneously in hyperlipidemia?

TL;DR: It seems that in hyperlipidemia, some platelets are in an activated state in circulation, and that increased lipid peroxidation, early apoptosis, platelet-leukocytes aggregate formation and platelet aggregation altogether accompany this process.
Journal ArticleDOI

The impact of platelet functions and inflammatory status on the severity of preeclampsia.

TL;DR: The severity of inflammation is found to be independent from the intensity of platelet activation in preeclamptic women, and seems to be related to mechanisms causing alterations of cytokine levels such as IL-8 and IL-10, rather than plateletactivation.
Journal ArticleDOI

Apo A-I Binding to Platelets Detected by Flow Cytometry

TL;DR: It is demonstrated that apolipoprotein (apo) A-I can bind to platelets, and this supports the hypothesis that apo A- I may play a major role in HDL binding to platelet interactions.